April 24th 2024, 9:00pm
By Brielle Benyon
With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers before treatment, a nurse said.
April 24th 2024, 7:00pm
Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.
April 24th 2024, 5:00pm
By Carla Deschamps
At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying cancer-free.
April 24th 2024, 3:00pm
By Phillip Belfiori
Even though I lost my hair from cancer treatment, I didn't let that stop me from styling my hair with attitude.
April 24th 2024, 1:00pm
By Ashley Chan
Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.
April 23rd 2024, 9:00pm
By Alex Biese
Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.
April 23rd 2024, 7:01pm
The FDA has granted accelerated approval to Ojemda for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with a BRAF fusion or rearrangement, or BRAF V600 mutation.
April 23rd 2024, 5:00pm
By Georgia Hurst
While strolling through the woods, my eyes landed on a woodpecker, whose actions sparked a cancer analogy in my mind.
April 23rd 2024, 4:38pm
Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.
April 23rd 2024, 3:00pm
The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute myeloid leukemia.
April 23rd 2024, 1:00pm
By Joe Guastella
When my wife was diagnosed with stage 3B melanoma, we decided to openly speak about our fears.
April 22nd 2024, 11:48pm
A treatment combination of Anktiva and Bacillus Calmette-Guérin was approved by the FDA for certain patients with non-muscle-invasive bladder cancer.
April 22nd 2024, 9:00pm
A cognitive behavioral therapy for insomnia may help cancer survivors, along with ways to manage insomnia via sleep pressure, an expert told CURE®.
April 22nd 2024, 7:00pm
Patient/provider trust, education and lifestyle choices are crucial as Black men face higher incidence and mortality in prostate cancer, experts said.
April 22nd 2024, 5:00pm
By Mary Sansone
What it’s like having a “second birthday” after receiving a bone marrow transplant for my AML.
Nurse Suggests Questions to Ask Before Carvykti Treatment for Myeloma
Carvykti Provides Good Long-Term Quality of Life in Pretreated Myeloma
Receiving Chemotherapy for Colon Cancer on My Birthday
Attitudes With Latitude About My Cancer